Galderma Group Ltd header image

Galderma Group Ltd

GALD

Equity

ISIN CH1335392721 / Valor 133539272

SIX Swiss Exchange (2026-11-06)
CHF 191.75-1.74%

Galderma Group Ltd
UMushroom community rating:

star star star star star
4.06 6 votes No rating yet
NegativeNeutralPositive

About company

Galderma Group Ltd is a leading company in the dermatology sector, focusing exclusively on this field for over 40 years. The company specializes in developing, manufacturing, and marketing a wide range of dermatological treatments and solutions. Galderma's product portfolio includes therapeutic dermatology products, dermatological skincare, and injectable aesthetic treatments, catering to a diverse range of skin health needs. With a global presence, the company operates research and development centers and manufacturing facilities strategically located around the world. Galderma is dedicated to advancing the field of dermatology through continuous innovation and science-based solutions, aiming to enhance the quality of life for patients with various skin conditions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

29.6%1Y
%3Y
%5Y

Performance

28.3%1Y
30.4%3Y
30.4%5Y

Volatility

Market cap

54611 M

Market cap (USD)

Daily traded volume (Shares)

580,421

Daily traded volume (Shares)

1 day high/low

100.6 / 98.35

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.06

6 votes
Performance:
starstarstarstarstar
4.28
Innovation:
starstarstarstarstar
4.00
Society:
starstarstarstarstar
3.83
Nature:
starstarstarstarstar
3.50
Lucas Dannhuaser
UK, 03 Nov 2026
star star star star star
Good equity to gain exposure to cosmetics industry with a history of good performance.
André Caquet
UK, 02 Nov 2026
star star star star star
good
Pe DB
Switzerland, 02 Oct 2026
star star star star star
Galderma combines fast growth, rising margins, innovation and a solid balance sheet. The main risks are its high valuation, reliance on a few products and sensitivity to consumer spending on aesthetics. It suits a small, growth-oriented position rather than a core holding.

EQUITIES OF THE SAME SECTOR

Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited Glenmark Pharmaceuticals Limited Valor: 3195888
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.32%INR 2,592.85
Alkem Laboratories Ltd.
Alkem Laboratories Ltd. Alkem Laboratories Ltd. Valor: 30689895
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.61%INR 5,265.20
Merck KGaA
Merck KGaA Merck KGaA Valor: 412799
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.06%EUR 148.75
Helen of Troy Ltd
Helen of Troy Ltd Helen of Troy Ltd Valor: 938381
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.90%USD 37.43
Draegerwerk AG & Co. KGaA
Draegerwerk AG & Co. KGaA Draegerwerk AG & Co. KGaA Valor: 330445
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.26%EUR 77.40
Pfizer Inc
Pfizer Inc Pfizer Inc Valor: 962004
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.93%USD 29.12
Metropolis Healthcare Ltd.
Metropolis Healthcare Ltd. Metropolis Healthcare Ltd. Valor: 11536062
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.36%INR 569.25
Basilea Pharmaceutica Ltd, Allschwil
Basilea Pharmaceutica Ltd, Allschwil Basilea Pharmaceutica Ltd, Allschwil Valor: 1143244
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.56%CHF 71.00
Newron Pharmaceuticals S.p.A.
Newron Pharmaceuticals S.p.A. Newron Pharmaceuticals S.p.A. Valor: 2791431
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.91%CHF 8.83
Demant A/S
Demant A/S Demant A/S Valor: 32651962
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.05%DKK 377.20